BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37345961)

  • 1. Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second reader.
    Jaouen T; Souchon R; Moldovan PC; Bratan F; Duran A; Hoang-Dinh A; Di Franco F; Debeer S; Dubreuil-Chambardel M; Arfi N; Ruffion A; Colombel M; Crouzet S; Gonindard-Melodelima C; Rouvière O
    Diagn Interv Imaging; 2023 Oct; 104(10):465-476. PubMed ID: 37345961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided diagnosis system for characterizing ISUP grade≥2 prostate cancers at multiparametric MRI: A cross-vendor evaluation.
    Transin S; Souchon R; Gonindard-Melodelima C; de Rozario R; Walker P; Funes de la Vega M; Loffroy R; Cormier L; Rouvière O
    Diagn Interv Imaging; 2019 Dec; 100(12):801-811. PubMed ID: 31350218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zone-specific computer-aided diagnosis system aimed at characterizing ISUP ≥ 2 prostate cancers on multiparametric magnetic resonance images: evaluation in a cohort of patients on active surveillance.
    Arber T; Jaouen T; Campoy S; Rabilloud M; Souchon R; Abbas F; Moldovan PC; Colombel M; Crouzet S; Ruffion A; Neuville P; Rouvière O
    World J Urol; 2023 Dec; 41(12):3527-3533. PubMed ID: 37845554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.
    Gaur S; Harmon S; Rosenblum L; Greer MD; Mehralivand S; Coskun M; Merino MJ; Wood BJ; Shih JH; Pinto PA; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2018 Jul; 211(1):W33-W41. PubMed ID: 29733695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a Region of Interest-based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database-CAD-FIRST Study.
    Couchoux T; Jaouen T; Melodelima-Gonindard C; Baseilhac P; Branchu A; Arfi N; Aziza R; Barry Delongchamps N; Bladou F; Bratan F; Brunelle S; Colin P; Correas JM; Cornud F; Descotes JL; Eschwege P; Fiard G; Guillaume B; Grange R; Grenier N; Lang H; Lefèvre F; Malavaud B; Marcelin C; Moldovan PC; Mottet N; Mozer P; Potiron E; Portalez D; Puech P; Renard-Penna R; Roumiguié M; Roy C; Timsit MO; Tricard T; Villers A; Walz J; Debeer S; Mansuy A; Mège-Lechevallier F; Decaussin-Petrucci M; Badet L; Colombel M; Ruffion A; Crouzet S; Rabilloud M; Souchon R; Rouvière O
    Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38493072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A concurrent, deep learning-based computer-aided detection system for prostate multiparametric MRI: a performance study involving experienced and less-experienced radiologists.
    Labus S; Altmann MM; Huisman H; Tong A; Penzkofer T; Choi MH; Shabunin I; Winkel DJ; Xing P; Szolar DH; Shea SM; Grimm R; von Busch H; Kamen A; Herold T; Baumann C
    Eur Radiol; 2023 Jan; 33(1):64-76. PubMed ID: 35900376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate Biopsy.
    Dinh AH; Melodelima C; Souchon R; Moldovan PC; Bratan F; Pagnoux G; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
    Radiology; 2018 May; 287(2):525-533. PubMed ID: 29361244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study).
    Rouvière O; Souchon R; Lartizien C; Mansuy A; Magaud L; Colom M; Dubreuil-Chambardel M; Debeer S; Jaouen T; Duran A; Rippert P; Riche B; Monini C; Vlaeminck-Guillem V; Haesebaert J; Rabilloud M; Crouzet S
    BMJ Open; 2022 Feb; 12(2):e051274. PubMed ID: 35140147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prebiopsy multiparametric MRI and PI-RADS version 2.0 for differentiating histologically benign prostate disease from prostate cancer in biopsies: A retrospective single-center comparison.
    Tosun M; Uslu H
    Clin Imaging; 2021 Oct; 78():98-103. PubMed ID: 33773450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
    Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
    Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis.
    Lim CS; Abreu-Gomez J; Thornhill R; James N; Al Kindi A; Lim AS; Schieda N
    Abdom Radiol (NY); 2021 Dec; 46(12):5647-5658. PubMed ID: 34467426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
    Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
    AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS; Abreu-Gomez J; Carrion I; Schieda N
    AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study).
    Di Franco F; Souchon R; Crouzet S; Colombel M; Ruffion A; Klich A; Almeras M; Milot L; Rabilloud M; Rouvière O;
    Insights Imaging; 2023 Mar; 14(1):49. PubMed ID: 36939970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
    J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3 + 4 and 4 + 3 prostate cancer.
    Alessandrino F; Taghipour M; Hassanzadeh E; Ziaei A; Vangel M; Fedorov A; Tempany CM; Fennessy FM
    Abdom Radiol (NY); 2019 Jan; 44(1):279-285. PubMed ID: 30066169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.